<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03028194</url>
  </required_header>
  <id_info>
    <org_study_id>MHST2014-06</org_study_id>
    <nct_id>NCT03028194</nct_id>
  </id_info>
  <brief_title>Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia</brief_title>
  <official_title>Effects of Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia: A Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Thomas Hospital, Panama</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Thomas Hospital, Panama</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of Postpartum uterine curettage in reducing hospitalization time or in improving the
      clinical evolution of the patient with preeclampsia/eclampsia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate if postpartum uterine curettage improved the clinical and laboratory parameters
      in patients with preeclampsia or eclampsia.

      A total of 442 patients with preeclampsia/eclampsia were randomized to postpartum curettage
      (223) or no procedure (219). Systolic and diastolic blood pressure were recorded and analyzed
      at hours 6, 12, 24 and 48. Also, several laboratory values and diuresis were evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2015</start_date>
  <completion_date type="Actual">December 11, 2016</completion_date>
  <primary_completion_date type="Actual">October 31, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>6 hours</time_frame>
    <description>Arterial blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>12 hours</time_frame>
    <description>Arterial blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>24 hours</time_frame>
    <description>Arterial blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>48 hours</time_frame>
    <description>Arterial Blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).</measure>
    <time_frame>6 hours</time_frame>
    <description>Number of patients with an abnormal laboratory value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).</measure>
    <time_frame>12 hours</time_frame>
    <description>Number of patients with an abnormal laboratory value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).</measure>
    <time_frame>24 hours</time_frame>
    <description>Number of patients with an abnormal laboratory value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory results (hypertensive disorder profile: hemoglobin, hematocrit, platelets, renal or liver function tests).</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of patients with an abnormal laboratory value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Seizures</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of participants with the development of seizures after birth.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">442</enrollment>
  <condition>Pre-Eclampsia</condition>
  <condition>Eclampsia</condition>
  <arm_group>
    <arm_group_label>Curettage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postpartum uterine curettage performed immediately after delivery of the placenta.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No procedure performed after delivery of the placenta.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Curettage</intervention_name>
    <description>Postpartum uterine curettage with a sharp curette # 14 or #16, immediately after delivery of the placenta.</description>
    <arm_group_label>Curettage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>No procedure after delivery of the placenta</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Gestational age 24 weeks or more.

          -  Preeclampsia/eclampsia

        Exclusion Criteria:

          -  Epilepsy or seizures previous to pregnancy.

          -  Renal disease

          -  Heart disease

          -  Liver disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osvaldo Reyes, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Saint Thomas Hospital, Panama</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Saint Thomas H</name>
      <address>
        <city>Panama</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Maternity Hospital</name>
      <address>
        <city>Panama</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2017</study_first_submitted>
  <study_first_submitted_qc>January 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2017</study_first_posted>
  <last_update_submitted>January 20, 2017</last_update_submitted>
  <last_update_submitted_qc>January 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint Thomas Hospital, Panama</investigator_affiliation>
    <investigator_full_name>Osvaldo A. Reyes T.</investigator_full_name>
    <investigator_title>Head of the Research Department</investigator_title>
  </responsible_party>
  <keyword>Pre-eclampsia</keyword>
  <keyword>Eclampsia</keyword>
  <keyword>Postpartum uterine curettage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Eclampsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

